GeroScience · Nov 16, 2026
Dietary nucleotides and NAD+ precursors in age-related sarcopenia
By Gdańska A, Karaś R, Binduga UE et al.
Sarcopenia is a progressive, age-related skeletal muscle disorder characterised by reduced muscle strength, accompanied by loss of muscle mass and impaired muscle function. Growing interest in nutrition in older adults has also increased attention to nucleotides as potentially relevant dietary components that may participate in muscle regeneration, energy metabolism, and cellular responses to stress. The aim of this review was to critically evaluate evidence on conventional dietary nucleotides, nucleoproteins, and compounds related to NAD+ metabolism in the context of muscle ageing and sarcopenia. A structured literature review was conducted, with study identification and selection carried out in accordance with selected elements of PRISMA 2020. A total of 3090 records were identified in PubMed/MEDLINE, Scopus, and the Web of Science Core Collection. After removal of 1327 duplicates, 1763 unique records were screened. Of 159 publications assessed in full text, 62 were retained. Three additional clinical reports identified during revision brought the qualitative synthesis to 65 publications. The most direct evidence for conventional nucleotides comes from cellular and animal models and from several human intervention studies. These findings indicate the potential to attenuate atrophy, support myogenesis, and improve selected functional outcomes. Evidence on NAD+ precursors is considerably more extensive, but the clinical findings are heterogeneous. Nucleotides remain a promising but experimental nutritional strategy. Current evidence does not justify considering mixtures of AMP, CMP, GMP, and UMP, nucleoproteins, NMN, and NR as equivalent interventions or recommending their routine use in the treatment of sarcopenia.
doi.org/10.1007/s11357-026-02659-0Open accessPubMed 43040062Interventions